TABLE 2.
Name | Sequence (5′-3′)a | Reference |
---|---|---|
Eub27F | AGA GGT TGA TCM TGG CTC AG | 30 |
Eub1492R | TAC GGC TAC CTT GTT ACG ACT T | 30 |
Eub338F | ACT CCT ACG GGA GGC AGC | 5 |
Eub536R | GTA TTA CCG CGG CTG CTG G | 35 |
alpha303R | CCC AGT GTT GCT GAT CAT | This study |
ins63bpR | CCA TCA AAT GCC ACC AAA C | This study |
Eub338 | Bio/GCT GCC TCC CGT AGG AGT | 5 |
Osc611 | Bio/CCA CAG TTA AGC TGT GGT | This study |
nonOsc611 | Bio/CCA CAG TTT AGC TGT GGT | This study |
Syn611 | Bio/CAG TGG TTG AGC CAC TGG | This study |
nonSyn611 | Bio/CAG TGG TTC AGC CAC TGG | This study |
H595 | CTT TGA CAG CAG ACT T | This study |
H629 | CAG TTT CCA CTG CCT TT | This study |
Bio, biotin.